CLASS-LEADING TECHNOLOGY PLATFORM
MiRXES’ patented quantitative reverse transcriptase polymerase chain reaction (RT-qPCR) technology platform enables sensitive, specific, and robust detection of microRNAs and other non-coding RNAs in biofluids and tissue samples.
Independently validated to be more sensitive than other RT-qPCR technology platforms for microRNA quantification.
Unique RT Primer
Specific Real-Time PCR Primers
microRNA-specific forward and reverse real-time PCR primers confer further specificity and enable robust amplification.
Tailored RT-qPCR Reagents
Optimized RT and qPCR master mixes that enhance signal-to-noise ratio.
validated class-leading performance
This ease of use enables even first time users to generate consistent results from technical and biological replicates.